Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting.
IDH (isocitrate dehydrogenase) gene mutations are present in most diffuse low-grade gliomas and define the clinico-pathological core of the respective morphologically defined entities. Conversely, according to the 2016 WHO classification, the majority of glioblastomas belong to the IDH-wildtype cate...
| Publicado en: | Virchows Archiv: European Journal of Pathology Vol. 471; no. 5; pp. 641 - 650 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Nov2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |